|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
Stephen Saad
|
|
gptkbp:country
|
gptkb:South_Africa
|
|
gptkbp:founded
|
1997
|
|
gptkbp:founder
|
Stephen Saad
Gus Attridge
|
|
gptkbp:hasCompany
|
yes
|
|
gptkbp:headquarters_location
|
gptkb:Durban
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Aspen Pharmacare
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:JSE_Top_40
|
|
gptkbp:manufacturingFacilities
|
gptkb:Australia
gptkb:Brazil
gptkb:China
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Kenya
gptkb:Mexico
gptkb:Netherlands
gptkb:South_Africa
gptkb:Tanzania
|
|
gptkbp:market
|
over 50 countries
|
|
gptkbp:notableAcquisition
|
GlaxoSmithKline thrombosis business
Pfizer infant nutrition business (South Africa)
Sigma Pharmaceuticals (Australia)
|
|
gptkbp:notableEvent
|
COVID-19 vaccine production in South Africa
WHO prequalification for antiretrovirals
|
|
gptkbp:notableProduct
|
anaesthetics
antiretrovirals
oncology medicines
nutritionals
thrombosis medicines
|
|
gptkbp:numberOfEmployees
|
over 9,000
|
|
gptkbp:parentCompany
|
Aspen Pharmacare Holdings Limited
|
|
gptkbp:partner
|
gptkb:Johnson_&_Johnson
gptkb:Serum_Institute_of_India
GlaxoSmithKline
|
|
gptkbp:products
|
over-the-counter medicines
branded pharmaceuticals
generic medicines
|
|
gptkbp:revenue
|
R38.6 billion (2023)
|
|
gptkbp:servesArea
|
global
|
|
gptkbp:stockExchange
|
gptkb:Johannesburg_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:APN
|
|
gptkbp:website
|
https://www.aspenpharma.com/
|
|
gptkbp:bfsParent
|
gptkb:Marevan
|
|
gptkbp:bfsLayer
|
6
|